Series of domestic pharmaceuticals’ approvals to start global Phase 1 clinical trials

Domestic pharmaceutical companies are actively attempting to expand to the U.S. and European markets.

According to the industry concerned on the 10^th, a series of news have continued about Phase 1 clinical trials over a number of companies’ new drugs and drug candidates.

Chong Kun Dang acquired approval of a Phase 1 clinical trial over ‘CKD-506,’ which are currently being developed as an auto...